Early response assessment to targeted therapy in metastatic clear cell renal cancer using 68Ga-PSMA-11 PET/CT and comparison with CECT: a feasibility study
Clinical and Translational Imaging · 09.04.2024 · 12 (4) · 431-440
DOI: 10.1007/s40336-024-00627-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Imaging, online erschienen am 09.04.2024. Verfasst von Piyush Aggarwal und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Aggarwal, P., Singh, H., Das, C. K., Mavuduru, R. S., Lal, A., Kakkar, N., Kumar, R., Gorsi, U., Prashar, P., & Mittal, B. R. (2024). Early response assessment to targeted therapy in metastatic clear cell renal cancer using 68Ga-PSMA-11 PET/CT and comparison with CECT: a feasibility study. Clinical and Translational Imaging, 12(4), 431-440. https://doi.org/10.1007/s40336-024-00627-2
Vancouver
Aggarwal P, Singh H, Das CK, Mavuduru RS, Lal A, Kakkar N, et al. Early response assessment to targeted therapy in metastatic clear cell renal cancer using 68Ga-PSMA-11 PET/CT and comparison with CECT: a feasibility study. Clinical and Translational Imaging. 2024;12(4):431-440. doi:10.1007/s40336-024-00627-2
BibTeX
@article{Aggarwal2024,
author = {Aggarwal, Piyush and Singh, Harmandeep and Das, Chandan K. and Mavuduru, Ravimohan S. and Lal, Anupam and Kakkar, Nandita and Kumar, Rajender and Gorsi, Ujjwal and Prashar, Pratibha and Mittal, Bhagwant R.},
title = {Early response assessment to targeted therapy in metastatic clear cell renal cancer using 68Ga-PSMA-11 PET/CT and comparison with CECT: a feasibility study},
journal = {Clinical and Translational Imaging},
year = {2024},
volume = {12},
number = {4},
pages = {431--440},
doi = {10.1007/s40336-024-00627-2}
}
EUVIMED